中國人壽(02628.HK):將於4月26日召開2024年第一季度業績發佈會
格隆匯4月17日丨中國人壽(02628.HK)公佈,公司擬於2024年4月26日在香港交易及結算所有限公司「披露易」網站(www.hkexnews.hk)公佈公司2024年第一季度業績。為了便於廣大投資者更全面深入地瞭解本公司2024年第一季度業績和經營情況,公司擬於2024年4月26日19:00-20:15通過網絡直播及文字互動方式召開2024年第一季度業績發佈會。公司總裁利明光先生,其他高級管理人員及一名獨立非執行董事將出席業績發佈會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.